Alpine Associates Management Inc. Takes Position in Semler Scientific Inc. $SMLR

Alpine Associates Management Inc. acquired a new stake in Semler Scientific Inc. (NASDAQ:SMLR) in the third quarter, Holdings Channel.com reports. The firm acquired 95,600 shares of the company’s stock, valued at approximately $2,868,000.

Several other hedge funds also recently bought and sold shares of the company. RFG Advisory LLC bought a new stake in Semler Scientific during the 3rd quarter worth approximately $3,441,000. IMC Chicago LLC bought a new position in shares of Semler Scientific in the third quarter worth $2,799,000. Generali Asset Management SPA SGR bought a new position in shares of Semler Scientific in the second quarter worth $2,712,000. Pinnacle Wealth Management LLC purchased a new stake in shares of Semler Scientific in the second quarter worth $1,796,000. Finally, Geode Capital Management LLC boosted its stake in Semler Scientific by 26.1% during the second quarter. Geode Capital Management LLC now owns 215,104 shares of the company’s stock valued at $8,335,000 after buying an additional 44,470 shares during the period. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Down 4.9%

Shares of NASDAQ:SMLR opened at $20.33 on Friday. The stock’s 50-day moving average price is $19.20 and its 200-day moving average price is $25.05. Semler Scientific Inc. has a 12-month low of $14.89 and a 12-month high of $66.50. The stock has a market capitalization of $310.74 million, a P/E ratio of 7.31 and a beta of 1.32. The company has a current ratio of 1.97, a quick ratio of 1.95 and a debt-to-equity ratio of 0.21.

Semler Scientific (NASDAQ:SMLR) last released its earnings results on Wednesday, November 12th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $1.21. Semler Scientific had a return on equity of 34.21% and a net margin of 130.80%.The company had revenue of $7.49 million during the quarter, compared to analyst estimates of $7.87 million.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “hold (c-)” rating on shares of Semler Scientific in a research report on Monday, December 29th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Semler Scientific currently has an average rating of “Moderate Buy” and an average price target of $75.33.

Semler Scientific Profile

Semler Scientific, Inc, headquartered in Princeton, New Jersey, is a medical technology company specializing in the development and commercialization of non-invasive monitoring solutions for intracranial pressure. The company’s core focus is on improving patient care in neurocritical and acute care settings by providing clinicians with advanced diagnostic tools that reduce the risks associated with invasive procedures.

The company’s flagship product, the NICO Monitor, employs proprietary acoustic monitoring technology to continuously estimate intracranial pressure and compliance at the bedside.